if anything, pestell is a very smart individual. having him on board so he can maximize his eventual $$ return on his massive ( and more massive as of settlement ) stock holdings is not a bad idea, his pre-cytodyn resume speaks volumes, look it up. he was one of the reasons i invested in the first place. but what a fiasco his record has been with cytodyn. inexplicable bad promises. sold us a company that is potentially worthless. did he intentionally bamboozle cytodyn? i dont think so, or hope not.

i will be fair and state that in the past there were plenty of mistakes on both sides

1 - cytodyn offering him a huge percentage of the company for him and his IP, believing his yet unproven test and data were going to be valid, which they eventually were not...how did it look so good and turn out so bad?

2 - pestells' failure of the test, and trying to stall nader due to his fears of safety in the cancer study at the time.

what we dont know is why his test failed, or why he was so fearful and adamant about the safety issues. again his resume speaks volumes, but this chapter would count as a failure in his history. so how was he able to rectify his position with the company after all that? what is his explanation for all that went wrong?

it must be good, they brought him back on board...im going to guess that he is a very effective master negotiator.

maybe the test is functional now or close to it, who knows. my notes are slim on this subject but i believe his test was to be a much less invasive biopsy vs current protocol, which would and he stated that he was developing a blood test to eliminate biopsy altogether, or something along those lines.

clearly he REALLY believes in the drug as he could have dumped and ran a long time ago. there is most definitely more going on than meets the eye, most definitely good news for us. so im on board with him for the time being, as long as his success means my success also.